About Conference

The 11th International Conference on Vascular Dementia and Neurodegenerative Diseases will be held on August 14-15, 2025, in Amsterdam, Netherlands. This key event will bring together experts, researchers, healthcare professionals, and thought leaders in the fields of neurology, geriatrics, and neurodegenerative diseases to discuss the latest research, clinical practices, and advancements related to vascular dementia, Alzheimer’s disease, Parkinson’s disease, and other neurodegenerative conditions.

Key Themes and Focus Areas

The conference will cover a wide range of topics, addressing both the scientific and clinical aspects of vascular dementia and neurodegenerative diseases, including:

• Vascular Dementia: Exploring the pathophysiology, diagnosis, treatment strategies, and prevention of vascular dementia, a condition linked to impaired blood flow in the brain.
• Alzheimer’s Disease: Updates on the latest research, biomarkers, early detection methods, and therapeutic approaches for Alzheimer’s, one of the most prevalent neurodegenerative diseases.
• Parkinson’s Disease: Addressing the motor and non-motor symptoms of Parkinson’s disease, along with advancements in treatments, therapies, and brain stimulation techniques.
• Neurodegeneration and Aging: Understanding how the aging process contributes to neurodegenerative diseases and the role of lifestyle, genetics, and environmental factors.
• Neuroimaging and Biomarkers: Advances in brain imaging technologies and biomarkers for early diagnosis and monitoring of neurodegenerative diseases.
• Cognitive Impairment and Dementia: Investigating different types of dementia, including frontotemporal dementia, Lewy body dementia, and the overlapping symptoms of these conditions with vascular dementia.
• Drug Development and Clinical Trials: Updates on the latest clinical trials, pharmacological treatments, and drug development aimed at slowing or halting the progression of neurodegenerative diseases.
• Neuroinflammation and Brain Health: Examining the role of neuroinflammation in neurodegeneration and its potential as a target for therapeutic intervention.
• Caregiver Support and Management: Addressing the psychological, emotional, and logistical challenges faced by caregivers of patients with neurodegenerative diseases.

Objective

The primary aim of the conference is to promote global collaboration and exchange of knowledge in the fields of vascular dementia and neurodegenerative diseases. The event will focus on sharing cutting-edge research, fostering discussions on clinical best practices, and encouraging partnerships that will drive improvements in the diagnosis, treatment, and care of individuals affected by these conditions.

Benefits of Attending

• Learn from Experts: Gain insights from leading researchers, clinicians, and neurologists who are at the forefront of advancements in neurodegenerative diseases.
• Present Research: Researchers and healthcare professionals will have the opportunity to present their findings, case studies, and innovations in the diagnosis and treatment of vascular dementia and neurodegenerative diseases.
• Networking Opportunities: Connect with professionals from around the world who are dedicated to improving the care and treatment of individuals with dementia and neurodegenerative diseases.
• Workshops and Interactive Sessions: Participate in specialized workshops and interactive sessions focused on the latest diagnostic techniques, treatment options, and care strategies.
• Explore New Technologies: Discover emerging technologies, tools, and innovations in neuroimaging, diagnostic methods, and patient care through exhibits and demonstrations.

Who Should Attend?

• Neurologists: Medical professionals specializing in the diagnosis and treatment of neurological disorders, particularly those related to dementia and neurodegeneration.
• Geriatricians: Specialists in aging and age-related conditions, including neurodegenerative diseases, and those involved in caring for elderly patients with cognitive decline.
• Researchers and Academics: Individuals conducting research in the areas of neuroscience, neurodegenerative diseases, dementia, and neuroimaging.
• Nurses and Caregivers: Healthcare professionals and caregivers who work closely with patients suffering from neurodegenerative diseases and dementia.
• Pharmaceutical and Biotech Professionals: Companies developing drugs, medical devices, or technologies aimed at the diagnosis, treatment, and management of dementia and neurodegenerative diseases.
• Students and Trainees: Students and young professionals studying neurology, neuroscience, geriatrics, or related fields who are interested in learning about the latest research and clinical practices.

Session & tracks 

1. Introduction to Vascular Dementia: Understanding the Basics

An overview of vascular dementia, its definition, causes, and risk factors, setting the stage for a deeper understanding of the disease.

2. The Role of Stroke in Vascular Dementia

Exploring how stroke events can lead to cognitive decline and increase the risk of vascular dementia.

3. Early Symptoms and Diagnosis of Vascular Dementia

A session on recognizing the early symptoms of vascular dementia and the diagnostic tools used by clinicians.

4. Neuroimaging in Vascular Dementia: Techniques and Applications

Discussing various neuroimaging techniques like MRI and CT scans to understand the progression of vascular dementia.

5. The Role of Genetics in Vascular Dementia and Alzheimer’s

Examining the genetic factors and how they influence susceptibility to vascular dementia and other neurodegenerative diseases.

6. Managing Risk Factors for Vascular Dementia

Strategies for managing risk factors like hypertension, diabetes, and cardiovascular diseases to prevent vascular dementia.

7. Neurodegenerative Diseases: An Overview

An in-depth look into various neurodegenerative diseases, their characteristics, and how they impact brain function.

8. Parkinson’s Disease and Vascular Dementia: A Complex Relationship

Exploring the overlap between Parkinson’s disease and vascular dementia, including shared risk factors and treatment options.

9. Alzheimer’s Disease vs. Vascular Dementia: Key Differences

Understanding the differences and similarities between Alzheimer’s disease and vascular dementia, both in terms of pathology and symptoms.

10. The Impact of Lifestyle on Dementia Progression

Discussing the influence of diet, exercise, and social engagement on slowing down the progression of vascular dementia and neurodegenerative diseases.

11. Pharmacological Treatments for Vascular Dementia

Exploring current medications used to manage vascular dementia symptoms and their effectiveness.

12. Cognitive Rehabilitation in Vascular Dementia

Examining cognitive rehabilitation strategies to help patients with vascular dementia maintain their cognitive abilities.

13. The Role of Inflammation in Neurodegenerative Diseases

Looking at the role of inflammation in the development of vascular dementia and other neurodegenerative diseases.

14. Neuroprotective Strategies in Vascular Dementia

An exploration of potential neuroprotective strategies, including medications and interventions that could help prevent brain damage.

15. Psychosocial Impact of Vascular Dementia on Patients and Families

A discussion on how vascular dementia affects the emotional well-being of both patients and caregivers.

16. Vascular Cognitive Impairment: A Precursor to Dementia

Exploring vascular cognitive impairment as an early stage of vascular dementia and its diagnostic and treatment challenges.

17. Genetic Predisposition to Neurodegenerative Diseases

This session focuses on how genetics predispose individuals to diseases like Alzheimer’s and vascular dementia.

18. The Role of Autopsy in Diagnosing Vascular Dementia

A look at how post-mortem examinations help confirm the diagnosis of vascular dementia and its different stages.

19. Advanced Neuroimaging in Neurodegenerative Diseases

Introducing advanced neuroimaging technologies that provide more detailed insight into the brain’s structural and functional changes.

20. Innovative Approaches in Early Detection of Vascular Dementia

Exploring cutting-edge methods in early diagnosis, such as biomarkers and AI-powered imaging techniques.

21. Vascular Dementia and the Aging Population

Discussing the growing prevalence of vascular dementia in the aging population and its societal impacts.

22. Management of Behavioral and Psychological Symptoms in Dementia

A comprehensive look at managing the behavioral and psychological symptoms of vascular dementia and neurodegenerative diseases.

23. The Role of Physical Therapy in Vascular Dementia

Examining how physical therapy can help patients with vascular dementia maintain mobility and quality of life.

24. Environmental Modifications for Dementia Care

Discussing environmental adjustments that can be made to assist individuals with vascular dementia in living more independently.

25. Future Directions in Vascular Dementia Research

A forward-looking session on the latest research, clinical trials, and innovative therapies that may transform how vascular dementia is treated.

Market analysis 

Neurodegenerative diseases, including vascular dementia, Alzheimer’s disease, Parkinson’s disease, and frontotemporal dementia, present a significant challenge globally, both in terms of public health and economic burden. As the global population ages, the prevalence of these diseases is on the rise, and this is driving demand for treatments, research, and caregiving solutions.

• Global Market Size: The global neurodegenerative disease therapeutics market is valued at billions of dollars, with a projected CAGR (Compound Annual Growth Rate) of 7–9% over the next decade. The vascular dementia market, while relatively smaller compared to Alzheimer’s, is expected to see strong growth due to the aging population and improvements in diagnostic technologies.
• Demographics: The rising elderly population worldwide, particularly in regions like North America, Europe, and parts of Asia-Pacific, is a significant factor driving the demand for neurodegenerative disease care, including vascular dementia treatment and management.

2. Key Market Drivers

• Aging Population: According to the UN, the number of people aged 60 years and older is growing globally, with projections estimating that 1 in 6 people will be over 60 by 2030. This directly correlates to an increased incidence of neurodegenerative diseases, such as Alzheimer’s, Parkinson’s, and vascular dementia.

• Awareness and Diagnosis: Increasing awareness about neurodegenerative diseases and early diagnosis techniques, such as neuroimaging, blood tests, and cognitive screenings, is helping to identify conditions earlier, which in turn drives demand for treatment and care options.

• Advances in Drug Development: The growing investment in research and development of disease-modifying drugs and novel therapeutics for neurodegenerative diseases is driving growth. Several pharmaceutical companies are working on disease-modifying treatments for Alzheimer’s and Parkinson’s, with vascular dementia also receiving increased attention.

• Research and Innovation: New technologies in imaging (e.g., MRI and PET scans), genetic studies, and clinical trials are advancing the understanding of these diseases and contributing to better diagnostic tools and treatments.

3. Market Challenges

• Lack of Effective Treatments: Although there has been some progress in the development of drugs for Alzheimer’s, Parkinson’s, and other neurodegenerative diseases, the market is still hindered by the lack of effective, long-term treatments. For vascular dementia specifically, treatment options remain limited, and research on pharmacological interventions is still ongoing.

• High Treatment Costs: The financial burden of caring for patients with neurodegenerative diseases is substantial. Long-term care, including residential care and home healthcare services, presents a significant economic challenge for families and healthcare systems.

• Regulatory Hurdles: The approval process for new drugs and treatments can be long and expensive. Neurodegenerative disease drugs face rigorous clinical trials to demonstrate efficacy and safety, and many have faced regulatory setbacks or failures in the market.

4. Market Opportunities

• Biomarker Discovery: The development of diagnostic biomarkers for neurodegenerative diseases offers a significant opportunity. Biomarkers can lead to earlier diagnosis, personalized treatment plans, and improved patient outcomes.

• Clinical Trials and Drug Development: The rising number of clinical trials for vascular dementia and neurodegenerative diseases presents growth opportunities. Breakthroughs in research could lead to new, effective therapies and drugs.

• Telemedicine and Digital Health Solutions: Digital health technologies, including telemedicine, wearable devices, and remote monitoring, are growing in popularity as they help manage symptoms, monitor cognitive function, and provide ongoing care for patients with neurodegenerative diseases.

• Global Market Expansion: Emerging markets, especially in Asia-Pacific, Latin America, and Africa, offer significant growth potential due to increasing healthcare investments and the rising incidence of age-related diseases.

5. Competitive Landscape

The competitive landscape of the vascular dementia and neurodegenerative diseases market includes pharmaceutical companies, biotechnology firms, and diagnostic technology developers. Some of the major players involved in the development of treatments for these diseases include:

• Biogen Inc.
• Eli Lilly and Co.
• Roche Holding AG
• Johnson & Johnson
• Novartis AG
• AbbVie Inc.
• Medtronic